105
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis

, , , , , , , & show all
Pages 13-23 | Published online: 24 Jan 2014

References

  • CosnesJGower-RousseauCSeksikPCortotAEpidemiology and natural history of inflammatory bowel diseasesGastroenterology201114061785179421530745
  • AbrahamCChoJHInflammatory bowel diseaseN Engl J Med2009361212066207819923578
  • MawdsleyJERamptonDSPsychological stress in IBD: new insights into pathogenic and therapeutic implicationsGut200554101481111491
  • HindryckxPLaukensDDe VosMBoosting the hypoxia-induced adaptive response in inflammatory bowel disease: a novel concept of treatmentInflamm Bowel Dis20111792019202221830277
  • CumminsEPDohertyGATaylorCTHydroxylases as therapeutic targets in inflammatory bowel diseaseLab Invest201393437838323419710
  • ShahBMayerLCurrent status of monoclonal antibody therapy for the treatment of inflammatory bowel diseaseExpert Rev Clin Immunol20106460762020594134
  • NeurathMFTravisSPMucosal healing in inflammatory bowel diseases: a systematic reviewGut201261111619163522842618
  • WilsonBSLönnforsSVermeireSThe True Impact of IBD: A European Crohn’s and Ulcerative Colitis Patient LifeIMPACT Survey2010–2011 Available from: http://efcca-solutions.net/media/jointhefght/ImpactReport.pdfAccessed June 4, 2013
  • ColganSPTaylorCTHypoxia: an alarm signal during intestinal inflammationNat Rev Gastroenterol Hepatol20107528128720368740
  • GloverLEColganSPHypoxia and metabolic factors that influence inflammatory bowel disease pathogenesisGastroenterology201114061748175521530741
  • JamadarkhanaPChaudharyAChhipaLTreatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates ischemic acute kidney injuryAm J Nephrol201236320821822948183
  • BernhardtWMWiesenerMSScigallaPInhibition of prolyl hydroxylases increases erythropoietin production in ESRDJ Am Soc Nephrol20102132151215621115615
  • RobinsonAKeelySKarhausenJGerichMEFurutaGTColganSPMucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibitionGastroenterology2008134114515518166352
  • KarhausenJFurutaGTTomaszewskiJEJohnsonRSColganSPHaaseVHEpithelial hypoxia-inducible factor-1 is protective in murine experimental colitisJ Clin Invest200411481098110615489957
  • Committee for the Purpose of Control and Supervision on Experiments on AnimalsCPCSEA Guidelines for Laboratory Animal FacilityInd J Pharmacol2003354257274
  • DanielCSartoryNAZahnNRadekeHHSteinJMImmune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profileJ Pharmacol Exp Ther20083241233317911375
  • ZhangDKYuJJLiYMA Picrorhiza kurroa derivative, picroliv, attenuates the development of dextran-sulfate-sodium-induced colitis in miceMediators Inflamm2012201275162923125487
  • MorrisGPBeckPLHerridgeMSDepewWTSzewczukMRWallaceJLHapten-induced model of chronic inflammation and ulceration in the rat colonGastroenterology19899637958032914642
  • LunaLGManual of Histologic Staining Methods of the Armed Forces Institute of Pathology3rd edNew YorkMcGraw-Hill1968
  • KitajimaSTakumaSMorimotoMHistological analysis of murine colitis induced by dextran sulfate sodium of different molecular weightsExp Anim200049191510803356
  • MuranoNMuranoMIshidaKTherapeutic effect of SHI-219, a novel water soluble prodrug of EG626 (phtalazinol), on mouse dextran sodium sulfate-induced colitisBull Osaka Med Coll20065226979
  • NeurathMFussIStroberWTNBS-colitisInt Rev Immunol2000191516210723677
  • DielemanLAPalmenMJAkolHChronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokinesClin Exp Immunol199811433853919844047
  • OkayasuIHatakeyamaSYamadaMOhkusaTInagakiYNakayaRA novel method in the induction of reliable experimental acute and chronic ulcerative colitis in miceGastroenterology19909836947021688816
  • XueHSufitAJWischmeyerPEGlutamine therapy improves outcome of in vitro and in vivo experimental colitis modelsJPEN J Parenter Enteral Nutr201135218819721378248
  • HuSZhuXTriggsJRInflammation-induced, 3′UTR-dependent translational inhibition of Hsp70 mRNA impairs intestinal homeostasisAm J Physiol Gastrointest Liver Physiol20092965G1003G101119299581
  • HuSCiancioMJLahavMTranslational inhibition of colonic epithelial heat shock proteins by IFN-gamma and TNF-alpha in intestinal inflammationGastroenterology200713361893190418054561
  • LiedelJLGuoYYuYMother’s milk-induced Hsp70 expression preserves intestinal epithelial barrier function in an immature rat pup modelPediatr Res2011695 Pt 139540021263375